Mitochondrial malfunction in senescent cells drives chronic inflammation
Researchers discovered that aging senescent cells use malfunctioning mitochondria to activate inflammatory genes, keeping the immune system in a prolonged state of alert. Blocking this mitochondrial trigger reduced inflammation and improved healthy aging in mice. The findings point to a potential strategy for combating age-related decline.
Senescent cells, often called "zombie" cells, stop dividing but remain metabolically active, secreting inflammatory molecules through a program known as the senescence-associated secretory phenotype (SASP). The research team found that mitochondria in these cells produce excess acetyl-CoA, a metabolic molecule that modifies histone proteins and loosens DNA packaging. This structural change exposes inflammatory genes, making them more accessible for expression. Two converging pathways appear to drive this process: one alters how DNA is stored, while the other boosts expression of the exposed genes. In mouse studies, interrupting this mitochondrial trigger reduced inflammation and promoted healthier aging.
The findings, published in Nature, emerged from collaboration between Sanford Burnham Prebys Medical Discovery Institute and Mayo Clinic. Because chronic inflammation is linked to numerous age-related diseases, understanding its molecular origins may open new avenues for therapeutic intervention.
This research could reshape how age-related inflammation is approached clinically. If mitochondrial acetyl-CoA production proves to be a viable drug target, therapies might one day reduce chronic inflammation in older adults, potentially slowing progression of diseases like atherosclerosis, arthritis, or neurodegeneration. However, inflammation serves protective functions, so any intervention must be carefully balanced. The mouse results are promising but preliminary; human applications remain distant. Still, the work offers a concrete molecular mechanism that may guide future drug development and aging research.